Clinical Trial Update: A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating the efficacy, safety, and pharmacokinetics of ranibizumab delivered via the Port Delivery System in diabetic retinopathy wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• Lucentis (ranibizumab) (ranibizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetic Retinopathy | Phase 3 | Status: COMPLETED | Results posted: 2025-11-25